These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16126036)

  • 41. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence.
    Dutta S; Murki S; Varma S; Narang A; Chakrabarti A
    Indian Pediatr; 2005 Dec; 42(12):1226-30. PubMed ID: 16424560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time.
    Neely MN; Schreiber JR
    Pediatrics; 2001 Feb; 107(2):404-5. PubMed ID: 11158475
    [No Abstract]   [Full Text] [Related]  

  • 44. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant.
    Kicklighter SD; Springer SC; Cox T; Hulsey TC; Turner RB
    Pediatrics; 2001 Feb; 107(2):293-8. PubMed ID: 11158461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country.
    Rueda K; Moreno MT; Espinosa M; Sáez-Llorens X
    Pediatr Infect Dis J; 2010 Nov; 29(11):1050-2. PubMed ID: 20571460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal chemoprophylaxis after blood and marrow transplantation.
    Wingard JR
    Clin Infect Dis; 2002 May; 34(10):1386-90. PubMed ID: 11981735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluconazole for the prevention of fungal infections: get ready, get set, caution.
    Fanaroff AA
    Pediatrics; 2006 Jan; 117(1):214-5. PubMed ID: 16396881
    [No Abstract]   [Full Text] [Related]  

  • 48. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neonatal candidiasis: prophylaxis and treatment.
    Tiffany KF; Smith PB; Benjamin DK
    Expert Opin Pharmacother; 2005 Aug; 6(10):1647-55. PubMed ID: 16086651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
    Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
    Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical consequences of resistant Candida infections in intensive care.
    Montravers P; Jabbour K
    Int J Antimicrob Agents; 2006 Jan; 27(1):1-6. PubMed ID: 16343859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth.
    Kaufman DA; Gurka MJ; Hazen KC; Boyle R; Robinson M; Grossman LB
    Pediatr Infect Dis J; 2006 Aug; 25(8):733-7. PubMed ID: 16874174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluconazole use and safety in the nursery.
    Castagnola E; Jacqz-Aigrain E; Kaguelidou F; Maragliano R; Stronati M; Rizzollo S; Farina D; Manzoni P
    Early Hum Dev; 2012 May; 88 Suppl 2():S11-5. PubMed ID: 22633503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit.
    Devlin RK
    Adv Neonatal Care; 2006 Apr; 6(2):68-77; quiz 78-9. PubMed ID: 16618476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluconazole prophylaxis for prevention of invasive candidiasis in infants.
    Ericson JE; Benjamin DK
    Curr Opin Pediatr; 2014 Apr; 26(2):151-6. PubMed ID: 24626156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age.
    Kaufman DA; Cuff AL; Wamstad JB; Boyle R; Gurka MJ; Grossman LB; Patrick P
    J Pediatr; 2011 May; 158(5):759-765.e1. PubMed ID: 21168853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial.
    Patel R
    Liver Transpl; 2000 May; 6(3):376-9. PubMed ID: 10827245
    [No Abstract]   [Full Text] [Related]  

  • 59. Prophylactic regimens with fluconazole for candidiasis in neonates under 1.500g: A retrospective chart review of two cohorts.
    Silva-Rios J; Camargos P; Correa L; Romanelli R
    J Neonatal Perinatal Med; 2019; 12(1):29-36. PubMed ID: 30958318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Number needed to treat in fluconazole prophylaxis in the neonatal intensive care unit.
    Shieh HH; Ibidi SM; Gilio AE
    Pediatr Infect Dis J; 2011 May; 30(5):449; author reply 449. PubMed ID: 21490493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.